Terbinafine dose-dependently suppressed cell viability in HT29 cells. In SNU449 cells evaluated with Terbinafine and an untreated control, the reported result was that SQLE inhibition significantly downregulated the indicated oxysterol levels in HCC cells. Terbinafine treatment at 50 µM for 48 h strongly reduced SOAT1 mRNA expression in C4-2 cells. [1,2,3]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Terbinafine suppresses HT29 cell viability
Cell-based study · HT29 [1]
Terbinafine treatment dose-dependently suppressed cell viability in HT29 cells.
Literature-Reported Treatment Conditions
- Reported limits
- Not stated in the sentences used: dose, route, schedule, vehicle, control.
Methods and source locations
Compound reported in the paper: Terbinafine
The paper names Terbinafine without stating the salt or form; not verified as the hydrochloride form supplied as A10912. No dose conversion or lot validation.
Figure 7 legend (S223)
cell viability: cell viability — Figure 7 legend (S223)
Oxysterol levels in SNU449 cells
Cell-based study · SNU449 cells [2]
Terbinafine was evaluated in SNU449 cells with an untreated control. The reported result was that SQLE inhibition significantly downregulated the indicated oxysterol levels in HCC cells.
Literature-Reported Treatment Conditions
- Reported limits
- Not stated in the sentences used: dose, route, schedule, vehicle.
Methods and source locations
Compound reported in the paper: Terbinafine
The paper names Terbinafine without stating the salt or form; not verified as the hydrochloride form supplied as A10912. No dose conversion or lot validation.
Results > SQLE orchestrates oxysterols production in HCC cells by modulating cholesterol metabolism (S171); Figure 3 legend (S252)
The levels of indicated oxysterols: The levels of indicated oxysterols; comparator: untreated (Med) — Results > SQLE orchestrates oxysterols production in HCC cells by modulating cholesterol metabolism (S171); Figure 3 legend (S252)
Terbinafine reduces SOAT1 mRNA expression
Cell-based study · C4-2 cells [3]
C4-2 cells were treated with Terbinafine at 50 µM for 48 h. Treatment resulted in a strong reduction in SOAT1 mRNA expression.
Literature-Reported Treatment Conditions
- Treatment concentration
- 50 µM
- Exposure duration
- 48 h
- Reported limits
- Not stated in the sentences used: route, vehicle, control.
Methods and source locations
Compound reported in the paper: Terbinafine
The paper names Terbinafine without stating the salt or form; not verified as the hydrochloride form supplied as A10912. No dose conversion or lot validation.
Results > MiR-205 and SQLE regulate cholesterol synthesis in PCa cells (S45); Fig. 3 legend (S352)
Expression of SOAT1 mRNA: Expression of SOAT1 mRNA — Results > MiR-205 and SQLE regulate cholesterol synthesis in PCa cells (S45); Fig. 3 legend (S352)